While this doesn't fall under the heading of Good News, it is positive -- and these days that's a leap in the right direction.
When a coronavirus vaccine is available -- in months, or a year, or two years -- the Washington Post reports that scientists studying its genetic code believe the vaccine will be a long-lasting one, and not something needed to be developed for each new strain. For instance, the SARS epidemic a few years back was also a coronavirus. (The coronavirus is the generic name for this virus. The name of this specific, new strain is COVID-19.)
The vaccine would most likely be more along the lines of the measles or chickenpox vaccines, something that would provide immunity for many years.
“That’s a relatively small number of mutations for having passed through a large number of people,” said Peter Thielen, a molecular geneticist at the Johns Hopkins University Applied Physics Laboratory. “At this point, the mutation rate of the virus would suggest that the vaccine developed for SARS-CoV-2 would be a single vaccine, rather than a new vaccine every year like the flu vaccine.”
You can read the full article here.
Leave a Reply.
Robert J. Elisberg is a political commentator, screenwriter, novelist, tech writer and also some other things that I just tend to keep forgetting.
Feedspot Badge of Honor